Administering glycoprotein (GP) IIb/IIIa inhibitors during angioplasty provides further benefits in patients pretreated with clopidogrel.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1605, 2007-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1431-1433

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

By  

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Platelet inhibition by abciximab is reduced in patients with the A2 allele of the glycoprotein (GP) IIb/IIIa receptor

By  

Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Inhibitors of Platelets Glycoprotein IIb / IIIa (GP IIb / IIIa) Receptor: Rationale for their Use in Clinical Cardiology

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 7, 2004-09 ,pp. : 703-709

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions: a pharmacological and clinical review

By Anne Ganeshkumar   Gruberg Luis  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 335-348

Informa Healthcare

Access to resources Recommend Favorite